QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

DSGN

QT80Design Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
12.44
+0.51+4.27%
OverviewShort InterestFilings
DSGNQT80Design Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
12.44+4.27%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand62.46M
Perf Week18.14%
Market Cap745.11MForward P/E-EPS next Y-1.64Insider Trans0.00%Shs Float-Perf Month18.59%
Enterprise Value735.08MPEG0.54EPS next Q-0.36Inst Own-Short Float-Perf Quarter21.25%
Income-70860123.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y29.31%
Sales-P/B3.36EPS next Y-20.27%ROA-30.25%Short Interest-Perf YTD32.62%
Book/sh3.49P/C-EPS next 5Y-ROE-33.07%52W High17.25 -27.88%Perf Year238.04%
Cash/sh3.57P/FCF-EPS past 3/5Y-ROIC-35.67%52W Low3.33 273.57%Perf 3Y-
Dividend Est.-EV/EBITDA-10.64Sales past 3/5Y-Gross Margin0.00%Volatility3.94% 4.29%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-36.36%Oper. Margin0.00%ATR (14)0.84Perf 10Y-
Dividend Ex-Date-Quick Ratio22.28Sales Y/Y TTM-Profit Margin0.00%RSI (14)58.90Recom2.00
Dividend Gr. 3/5Y-Current Ratio22.28EPS Q/Q6.45%SMA2014.36%Beta1.33Target Price20.50
Payout0.00%Debt/Eq0.01Sales Q/Q-SMA500.86%Rel Volume1.18Prev Close11.93
Employees56LT Debt/Eq0.00EarningsAug 06SMA20029.61%Avg Volume880.41KPrice12.44
IPO DateMar 29, 2021Option/ShortYes / YesEPS/Sales Surpr.19.44% -Net Debt/EBITDA0.15Volume1,036,689Change4.27%
Analyst Ratings
DateActionAnalystRatingTarget
May-04-26ReiteratedOppenheimerOutperform$18 → $21
Apr-29-26ReiteratedPiper SandlerOverweight$12 → $20
Jan-07-26InitiatedOppenheimerOutperform$18
Dec-03-25InitiatedCraig-HallumBuy$15
Dec-03-25UpgradeLeerink PartnersMarket Perform → Outperform$14
Nov-20-25UpgradeRBC CapitalSector Perform → Outperform
May-07-24UpgradePiper SandlerNeutral → Overweight$42 → $12
Aug-15-23DowngradeSVB LeerinkOutperform → Market Perform
Aug-15-23DowngradeWedbushOutperform → Neutral
Aug-15-23DowngradeRBC CapitalOutperform → Sector Perform$30 → $7.00
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A111
Gross Profit-1-1-1
Selling, General and Administrative Excl. Other201821
Research and Development594457
Other Operating Expense000
Operating Income-79-62-78
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-10-13-11
Net Income Before Taxes-70-50-67
Income Taxes
000
Consolidated Net Income-70-50-67
Net Income From Continuing Operations-70-50-67
Net Income-70-50-67
EPS (Recurring)-1.22-0.88-1.19
EPS (Basic, Before Extraordinaries)-1.22-0.88-1.19
EPS (Diluted)-1.22-0.88-1.19
EBITDA-69-49-66
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding575756
Market Capitalization535——
Operating Lease Expense
———
Insider Trading Volume
$13.20$11.70$10.20$8.70$7.20● Close Price0.00M0.74M1.48M2.22M2.95MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
William ArsaniDirectorAug 13 '25Sale5.25562,6272,953,7921,000,000Aug 14 12:00 AM
Prasad DeepaDirectorDec 18 '24Sale6.273,80623,86420,000Dec 19 12:00 AM
William ArsaniDirectorAug 09 '24Sale4.25814,8743,463,2150Aug 12 12:00 AM
Schmid John P.DirectorMar 25 '24Buy3.7417,80966,60626,965Mar 25 12:00 AM
Berger Heather A.DirectorMar 25 '24Buy3.741,3004,8661,300Mar 25 12:00 AM
Schmid John P.DirectorMar 22 '24Buy3.629,15633,1339,156Mar 25 12:00 AM
LAPPE RODNEY WDirectorSep 29 '23Buy2.3521,00049,287133,024Oct 02 12:00 AM
William ArsaniDirectorMar 30 '21Buy20.001,400,00028,000,0002,732,501Sep 06 12:00 AM
Prasad DeepaDirectorAug 29 '23Buy2.3112,00027,67023,806Aug 30 12:00 AM
William ArsaniDirectorAug 29 '23Buy2.441,960,0004,782,4003,000,000Aug 30 12:00 AM
William ArsaniDirectorAug 28 '23Buy2.15275,000591,2501,040,000Aug 30 12:00 AM
Siffert Joao MDPresident and CEODec 20 '22Buy8.386,30052,763132,619Dec 21 12:00 AM
Siffert Joao MDPresident and CEODec 19 '22Buy8.471,1509,741126,319Dec 21 12:00 AM
George SimeonDirectorDec 20 '22Buy8.1440,000325,4326,526,476Dec 20 12:00 AM
SR One Capital Fund I Aggregator LPDirectorDec 20 '22Buy8.1440,000325,4326,526,476Dec 20 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR